The promise and reality of fixed-dose combinations with rifampicin. A joint statement of the International Union Against Tuberculosis and Lung Disease and the Tuberculosis Programme of the World Health Organization.
D001682:Biological Availability; D004338:Drug Combinations; D006801:Humans; D012293:Rifampin / Q000493:pharmacokinetics* / Q000627:therapeutic use; D012955:Societies, Medical; D014376:Tuberculosis / Q000188:drug therapy / Q000378:metabolism*; D014944:World Health Organization
D004338:Drug Combinations; D012293:Rifampin